Axsome Therapeutics Inc. (AXSM) Business Metric Overview

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Axsome Therapeutics Inc. (AXSM)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

84.62

-0.63%

Pre-market Jan 07, 2025, 06:03 AM EST

Axsome Therapeutics Inc. Revenue Breakdown

Quarter	Sep 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023
Product Revenue	103.74M	74.10M	70.75M	57.13M	46.02M	28.57M
Product Revenue Growth	+40.00%	+4.73%	+23.84%	+24.14%	+61.07%	n/a
Royalty Revenue	1.03M	903.00K	783.00K	667.00K	683.00K	272.00K
Royalty Revenue Growth	+13.62%	+15.33%	+17.39%	-2.34%	+151.10%	n/a

Revenue by Geography

Quarter	Dec 31, 2023	Dec 31, 2022
Non-Us Revenue	65.73M	900.00K
Non-Us Revenue Growth	+7203.89%	n/a
United States Revenue	197.22M	n/a
United States Revenue Growth	n/a	n/a

Operating Expense Breakdown

Quarter	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015	Mar 31, 2015
Selling, General, and Administrative Revenue	95.56M	103.55M	98.97M	86.81M	83.19M	78.94M	74.19M	61.50M	40.89M	31.16M	25.70M	18.83M	20.23M	16.34M	11.25M	10.36M	6.33M	7.24M	4.97M	5.22M	3.11M	2.45M	2.82M	2.30M	2.20M	2.44M	2.41M	1.95M	1.83M	1.74M	1.69M	1.82M	1.64M	1.53M	1.36M	946.62K	499.42K	456.41K	516.84K
Selling, General, and Administrative Revenue Growth	-7.72%	+4.63%	+14.01%	+4.35%	+5.39%	+6.39%	+20.64%	+50.39%	+31.23%	+21.23%	+36.53%	-6.92%	+23.75%	+45.30%	+8.58%	+63.62%	-12.50%	+45.59%	-4.84%	+67.85%	+27.26%	-13.25%	+22.59%	+4.38%	-9.69%	+1.18%	+23.61%	+6.79%	+4.76%	+3.35%	-7.26%	+10.97%	+7.18%	+12.72%	+43.31%	+89.54%	+9.42%	-11.69%	n/a
Research and Development Revenue	45.39M	49.85M	36.59M	30.80M	28.77M	20.58M	17.79M	14.69M	14.88M	15.79M	12.59M	13.78M	13.18M	14.50M	16.60M	17.38M	14.80M	10.54M	27.52M	19.21M	15.84M	11.00M	7.60M	7.15M	6.04M	5.55M	4.75M	4.49M	4.47M	5.01M	5.99M	5.81M	5.57M	5.30M	4.53M	2.21M	1.52M	1.63M	1.42M
Research and Development Revenue Growth	-8.96%	+36.26%	+18.78%	+7.08%	+39.77%	+15.67%	+21.10%	-1.24%	-5.80%	+25.48%	-8.68%	+4.56%	-9.12%	-12.61%	-4.54%	+17.50%	+40.34%	-61.69%	+43.30%	+21.28%	+43.92%	+44.72%	+6.32%	+18.38%	+8.83%	+16.79%	+5.75%	+0.51%	-10.71%	-16.34%	+3.07%	+4.27%	+5.11%	+17.05%	+105.00%	+44.84%	-6.39%	+14.98%	n/a